← FDA Drug Approvals (Drugs@FDA)

BREXPIPRAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON PHARMA INC · Approved 2024-10-21

Drug application

FDA Application #

ANDA213587

Application type

Abbreviated New Drug Application (Generic)

Brand name

BREXPIPRAZOLE

Generic name

Brexpiprazole

Active ingredients

BREXPIPRAZOLE

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

PRINSTON PHARMA INC

First approval

2024-10-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown